Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in pharmacology 2022, Vol.13, p.714408-714408
Hauptverfasser: Teng, Junjie, Zhou, Kai, Lv, Dongxiao, Wu, Changshun, Feng, Hong
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 714408
container_issue
container_start_page 714408
container_title Frontiers in pharmacology
container_volume 13
creator Teng, Junjie
Zhou, Kai
Lv, Dongxiao
Wu, Changshun
Feng, Hong
description
doi_str_mv 10.3389/fphar.2022.714408
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2674753942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2674753942</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_26747539423</originalsourceid><addsrcrecordid>eNqVirtOw0AQAE8RSIkgH0C3ZRob3wPbR4dCEJEgioIFZbSxN8kh587co8jfQ0FByzQzxTB2w4tcylrf7ocj-lwUQuQVV6qoR2zCy1Jmuubi4k-P2TSEz-IHqbUs1YR9zDEQbGhwPt7Dulms4DVFjMZZWNoutdTB7gxoo8nWjxmH5kgehzMYC28RDwTLd3hJ9gAPHVnXom-NdSe8Zpd77ANNf33FZk-LZv6cDd59JQpxezKhpb5HSy6FrSgrVd1JrYT8x_oNSk5LZw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2674753942</pqid></control><display><type>report</type><title>Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Teng, Junjie ; Zhou, Kai ; Lv, Dongxiao ; Wu, Changshun ; Feng, Hong</creator><creatorcontrib>Teng, Junjie ; Zhou, Kai ; Lv, Dongxiao ; Wu, Changshun ; Feng, Hong</creatorcontrib><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2022.714408</identifier><language>eng</language><ispartof>Frontiers in pharmacology, 2022, Vol.13, p.714408-714408</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,864,4488,27924</link.rule.ids></links><search><creatorcontrib>Teng, Junjie</creatorcontrib><creatorcontrib>Zhou, Kai</creatorcontrib><creatorcontrib>Lv, Dongxiao</creatorcontrib><creatorcontrib>Wu, Changshun</creatorcontrib><creatorcontrib>Feng, Hong</creatorcontrib><title>Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma</title><title>Frontiers in pharmacology</title><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2022</creationdate><recordtype>report</recordtype><recordid>eNqVirtOw0AQAE8RSIkgH0C3ZRob3wPbR4dCEJEgioIFZbSxN8kh587co8jfQ0FByzQzxTB2w4tcylrf7ocj-lwUQuQVV6qoR2zCy1Jmuubi4k-P2TSEz-IHqbUs1YR9zDEQbGhwPt7Dulms4DVFjMZZWNoutdTB7gxoo8nWjxmH5kgehzMYC28RDwTLd3hJ9gAPHVnXom-NdSe8Zpd77ANNf33FZk-LZv6cDd59JQpxezKhpb5HSy6FrSgrVd1JrYT8x_oNSk5LZw</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Teng, Junjie</creator><creator>Zhou, Kai</creator><creator>Lv, Dongxiao</creator><creator>Wu, Changshun</creator><creator>Feng, Hong</creator><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma</title><author>Teng, Junjie ; Zhou, Kai ; Lv, Dongxiao ; Wu, Changshun ; Feng, Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_26747539423</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Teng, Junjie</creatorcontrib><creatorcontrib>Zhou, Kai</creatorcontrib><creatorcontrib>Lv, Dongxiao</creatorcontrib><creatorcontrib>Wu, Changshun</creatorcontrib><creatorcontrib>Feng, Hong</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teng, Junjie</au><au>Zhou, Kai</au><au>Lv, Dongxiao</au><au>Wu, Changshun</au><au>Feng, Hong</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>13</volume><spage>714408</spage><epage>714408</epage><pages>714408-714408</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><doi>10.3389/fphar.2022.714408</doi></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2022, Vol.13, p.714408-714408
issn 1663-9812
1663-9812
language eng
recordid cdi_proquest_miscellaneous_2674753942
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
title Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T20%3A55%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Case%20Report:%20PTEN%20Mutation%20Induced%20by%20anti-PD-1%20Therapy%20in%20Stage%20IV%20Lung%20Adenocarcinoma&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Teng,%20Junjie&rft.date=2022-01-01&rft.volume=13&rft.spage=714408&rft.epage=714408&rft.pages=714408-714408&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2022.714408&rft_dat=%3Cproquest%3E2674753942%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2674753942&rft_id=info:pmid/&rfr_iscdi=true